average weight loss with glp-1 agonists glp 1 gip triple agonist Retatrutide is a triple-agonist drug targeting GLP- 1, GIP, and GLP-1R Agonists for Weight Loss
Description
This epidemic has created substantial demand for weight control medications
According to the Cleveland Clinic, the higher the dose of the GLP-1 agonist, the more extreme the effects
After years of work, the FDA approved this type of drug for diabetes
After 22 people at risk of developing diabetes took Cinnulin PF or a placebo for 12 weeks, Ziegenfuss and colleagues compared the two groups
doi:10.5414/cpp47651 153
